Share This Link

This response dismisses the patient’s cognitive distortion without engaging in therapeutic exploration. Major depressive disorder involves negative cognitive biases due to altered serotonin and dopamine signaling in the prefrontal cortex, impairing rational attribution of causality. This choice fails to facilitate cognitive restructuring, missing the opportunity to address neurocognitive mechanisms underlying overgeneralization.

This response shifts focus to cultural beliefs, irrelevant to the patient’s cognitive distortion. Depression involves altered amygdala-prefrontal cortex interactions, leading to negative self-attribution. Exploring cultural heritage does not address serotonin deficiency or facilitate cognitive reframing, making it ineffective for correcting overgeneralized thinking driven by neurochemical imbalances.

This response acknowledges self-criticism but fails to engage in active cognitive restructuring. Depression involves hyperactive amygdala responses and reduced prefrontal inhibition, perpetuating negative self-perceptions. Without guiding the patient to explore alternative explanations, this choice misses the chance to alter maladaptive neural pathways, limiting its therapeutic impact on distorted thinking.

Tube feedings or parenteral nutrition are invasive and may reinforce the patient’s delusional fears of harm, as they bypass voluntary control. Schizophrenia’s dopamine dysregulation heightens suspicion, and forced interventions could exacerbate paranoia by stimulating the amygdala, increasing stress responses and potentially worsening the patient’s mental state and compliance.

Allowing restaurant delivery does not directly address the poisoning delusion, as external food sources may still be perceived as unsafe due to hyperactive dopamine-driven paranoia in schizophrenia. This option fails to engage the patient’s trust or reduce amygdala-driven fear responses, making it unlikely to resolve the refusal to eat.

Supervised vending machine access may not alleviate the patient’s delusional belief in poisoning, as the source remains external and unverified. Schizophrenia’s dopamine excess in the mesolimbic pathway sustains mistrust, and this intervention does not directly counter the delusion, potentially leaving amygdala-driven fear responses unaddressed, reducing its effectiveness.

Attachment-Based Therapy focuses on interpersonal relationships, not trauma-specific processing, and is less effective for PTSD’s amygdala-driven fear memories. Mirtazapine enhances serotonin and norepinephrine but lacks strong evidence for PTSD, as it primarily addresses depression by modulating alpha-2 adrenergic receptors, not trauma-specific neural hyperactivity.

Dialectical Behavior Therapy targets emotional regulation for personality disorders, not PTSD’s trauma-specific memories. Lorazepam, a benzodiazepine, enhances GABA activity but is not recommended for PTSD, as it may suppress rather than process trauma-related amygdala hyperactivity, risking dependency and impairing long-term recovery.

Applied Behavior Analysis is used for autism, not PTSD, and does not address trauma-related neural changes. Atomoxetine, a norepinephrine reuptake inhibitor, targets ADHD by enhancing prefrontal norepinephrine but lacks efficacy for PTSD’s amygdala-driven fear responses, making it unsuitable for trauma treatment.

Acute stress disorder involves trauma-related symptoms like dissociation or hyperarousal following a traumatic event, driven by amygdala hyperactivity and cortisol dysregulation. The nurse’s symptoms stem from emotional overload, not personal trauma, making this diagnosis inappropriate, as it does not involve direct exposure to a traumatic stressor.

Derealization disorder involves persistent feelings of unreality or detachment, linked to altered temporoparietal neural activity. The nurse’s symptoms of worry and intrusive thoughts about the patient’s family reflect emotional exhaustion, not perceptual distortions, making derealization unrelated to the described empathetic overload.

Dissociative disorder involves disruptions in identity or memory, often linked to trauma and altered hippocampal-amygdala connectivity. The nurse’s symptoms are emotional, not dissociative, stemming from empathetic overload rather than trauma-induced neural changes, making this diagnosis irrelevant to the described scenario.

GABA inhibits neural activity, counteracting excitation, but its role in PTSD is secondary, modulating rather than driving fear memory formation. Glutamate is critical for memory consolidation in the amygdala, but pairing with GABA does not fully explain PTSD’s hyperarousal and fear encoding mechanisms.

Histamine regulates wakefulness and arousal but is not directly involved in PTSD’s fear memory encoding. GABA modulates inhibition but does not drive the excitatory processes in the amygdala critical for trauma-related memory consolidation, making this pair irrelevant to PTSD’s core neurochemistry.

Acetylcholine modulates attention and memory but is not a primary driver of PTSD’s fear responses. Serotonin influences mood but plays a secondary role in trauma memory encoding compared to glutamate and norepinephrine, which directly mediate amygdala hyperactivity in PTSD.

The hippocampus and amygdala modulate stress responses but are not part of the HPA axis. The parietal lobe processes sensory information, not stress hormones. The HPA axis involves cortisol release, driven by hypothalamic-pituitary-adrenal interactions, not these structures, making this choice incorrect.

The hindbrain regulates basic functions like breathing, not stress responses. The pyramidal nervous system and anterior cerebrum are not anatomical structures involved in the HPA axis. Cortisol release, critical for stress, is driven by hypothalamic-pituitary-adrenal interactions, not these regions.

The hepatic artery, parasympathetic nervous system, and acoustic nerve are unrelated to the HPA axis. The parasympathetic system modulates rest, not stress, while the HPA axis involves hypothalamic CRH, pituitary ACTH, and adrenal cortisol, driving the body’s stress response.

Divorce represents distress, not eustress, as it triggers negative emotional responses via heightened cortisol and amygdala activity, disrupting serotonin and dopamine balance. This chronic stress impairs prefrontal cortex function, leading to emotional dysregulation, unlike eustress, which promotes positive motivation and growth.

Job loss threat is distress, activating the HPA axis to release cortisol, increasing amygdala-driven anxiety. This disrupts serotonin signaling, impairing mood regulation, and does not foster positive motivation or growth, unlike eustress, which involves beneficial stress enhancing performance without overwhelming neural systems.

Financial strain is distress, elevating cortisol via HPA axis activation, increasing amygdala activity, and reducing prefrontal control, leading to anxiety. Unlike eustress, which promotes motivation through manageable challenges, this scenario causes negative emotional responses, disrupting serotonin and dopamine balance, impairing coping mechanisms.

Dissociative amnesia involves memory loss for specific events, linked to hippocampal dysfunction and stress-induced cortisol elevation. The patient’s persistent detachment and unreality feelings do not indicate memory loss but rather altered temporoparietal neural activity, making amnesia an incorrect diagnosis for the described symptoms.

Acute stress disorder involves trauma-related symptoms like hyperarousal or dissociation within a month of trauma, driven by amygdala hyperactivity. The patient’s chronic detachment suggests a persistent condition, not time-limited, making depersonalization disorder more likely than acute stress disorder’s transient neural dysregulation.

Disinhibited social engagement disorder, seen in children post-trauma, involves inappropriate social familiarity, linked to amygdala-prefrontal dysregulation. The patient’s symptoms of detachment and unreality are unrelated to social behavior, making this diagnosis inappropriate, as it does not involve temporoparietal perceptual distortions.

Self-directed violence is a risk in dissociative identity disorder but is a consequence, not the cause, of identity disruption. Trauma-induced changes in amygdala-hippocampal connectivity drive dissociation, not violence, which arises from emotional dysregulation secondary to fragmented identity states.

Chronic low self-esteem may co-occur in dissociative identity disorder but is not the primary cause. Identity disruption stems from trauma-induced neural changes, particularly in the amygdala and prefrontal cortex, leading to fragmented self-states, not primarily from self-esteem deficits.

Poor impulse control is a symptom in some dissociative identity disorder cases but not the cause. Identity disruption results from trauma-induced amygdala hyperactivity and hippocampal dysfunction, leading to dissociated states, not primarily from impulsivity, which is a secondary behavioral outcome.

Phenelzine, an MAOI, requires avoiding tyramine-rich foods, not selenium-rich foods. Tyramine interacts with MAOIs, causing hypertensive crises due to norepinephrine surges in the synaptic cleft. Selenium has no specific interaction with MAOIs, making this choice irrelevant to safe medication management.

Monitoring sodium and weight is unrelated to phenelzine’s mechanism or side effects. MAOIs primarily affect monoamine neurotransmitters, not electrolytes or fluid balance. This behavior does not address the critical dietary or drug interaction precautions necessary for safe MAOI use.

Support stockings and leg elevation address circulatory issues, not phenelzine’s risks. MAOIs increase monoamine levels, risking hypertensive crises with certain foods or drugs, not venous stasis. This behavior does not reflect understanding of phenelzine’s neurochemical interactions or safety requirements.